Norinchukin Bank The Purchases 4,696 Shares of Corteva, Inc. (NYSE:CTVA)

Norinchukin Bank The increased its stake in shares of Corteva, Inc. (NYSE:CTVA - Free Report) by 15.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 35,558 shares of the company's stock after buying an additional 4,696 shares during the quarter. Norinchukin Bank The's holdings in Corteva were worth $2,025,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of CTVA. Ossiam increased its stake in shares of Corteva by 4,274.4% in the fourth quarter. Ossiam now owns 209,052 shares of the company's stock valued at $11,908,000 after buying an additional 204,273 shares during the period. BI Asset Management Fondsmaeglerselskab A S lifted its holdings in Corteva by 67.6% in the fourth quarter. BI Asset Management Fondsmaeglerselskab A S now owns 22,775 shares of the company's stock valued at $1,297,000 after buying an additional 9,184 shares during the period. Capital International Inc. CA boosted its position in Corteva by 44.4% during the fourth quarter. Capital International Inc. CA now owns 654,125 shares of the company's stock valued at $37,259,000 after acquiring an additional 201,285 shares during the last quarter. Capital World Investors grew its holdings in Corteva by 2,874.6% during the 4th quarter. Capital World Investors now owns 12,812,151 shares of the company's stock worth $729,780,000 after acquiring an additional 12,381,436 shares during the period. Finally, Dimensional Fund Advisors LP increased its stake in shares of Corteva by 2.2% in the 4th quarter. Dimensional Fund Advisors LP now owns 4,794,086 shares of the company's stock valued at $273,062,000 after acquiring an additional 102,109 shares in the last quarter. Institutional investors own 81.54% of the company's stock.

Corteva Stock Performance

NYSE:CTVA traded down $0.21 during trading hours on Friday, reaching $61.50. The stock had a trading volume of 1,803,131 shares, compared to its average volume of 3,593,492. The stock has a market cap of $42.01 billion, a P/E ratio of 47.67, a price-to-earnings-growth ratio of 1.68 and a beta of 0.73. The stock has a 50 day simple moving average of $60.77 and a 200 day simple moving average of $60.35. The company has a debt-to-equity ratio of 0.08, a quick ratio of 0.93 and a current ratio of 1.45. Corteva, Inc. has a 12-month low of $50.01 and a 12-month high of $66.24.

Corteva (NYSE:CTVA - Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $0.32 earnings per share for the quarter, missing the consensus estimate of $0.34 by ($0.02). Corteva had a return on equity of 7.19% and a net margin of 5.36%. On average, research analysts forecast that Corteva, Inc. will post 2.96 EPS for the current fiscal year.

Corteva Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Monday, March 3rd were given a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 1.11%. The ex-dividend date was Monday, March 3rd. Corteva's dividend payout ratio (DPR) is currently 52.71%.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on CTVA. Oppenheimer upped their price objective on shares of Corteva from $70.00 to $72.00 and gave the company an "outperform" rating in a report on Friday, February 7th. KeyCorp boosted their price objective on Corteva from $70.00 to $71.00 and gave the company an "overweight" rating in a report on Monday, April 14th. Bank of America increased their target price on Corteva from $69.00 to $73.00 and gave the stock a "buy" rating in a report on Tuesday, February 11th. Citigroup upped their price objective on shares of Corteva from $69.00 to $74.00 and gave the stock a "buy" rating in a report on Wednesday, January 29th. Finally, Argus upgraded shares of Corteva from a "hold" rating to a "buy" rating and set a $69.00 price objective for the company in a report on Monday, March 31st. One research analyst has rated the stock with a sell rating, three have given a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $68.13.

Insider Activity at Corteva

In related news, insider Brian Titus sold 26,560 shares of the business's stock in a transaction on Thursday, February 20th. The stock was sold at an average price of $63.74, for a total transaction of $1,692,934.40. Following the sale, the insider now directly owns 11,347 shares in the company, valued at approximately $723,257.78. The trade was a 70.07 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.14% of the stock is currently owned by corporate insiders.

Corteva Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.